|
?:authorAffiliation
|
-
[\'Cancer Research UK Clinical Trials Unit, University of Birmingham Institute of Cancer and Genomic Sciences, Birmingham, UK g.millen@nhs.net.\', \'Department of Paediatric Oncology, Birmingham Women\'s and Children\'s NHS Foundation Trust, Birmingham, UK.\', \'Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.\', \'Centre for Computational Biology, University of Birmingham, Birmingham, UK.\', \'Leeds Institute for Data Analytics (LIDA), University of Leeds School of Medicine, Leeds, West Yorkshire, UK.\', \'CCLG Executive, Children\'s Cancer and Leukaemia Group, Leicester, UK.\', \'Leeds Institute of Medical Research, University of Leeds, Leeds, West Yorkshire, UK.\', \'School of Medicine, University of Nottingham Children\'s Brain Tumour Research Centre, Nottingham, UK.\', \'Cancer Research UK Clinical Trials Unit, University of Birmingham Institute of Cancer and Genomic Sciences, Birmingham, UK.\', \'Department of Oncology, University of Oxford, Oxford, Oxfordshire, UK.\', \'Division of Cancer Sciences, The University of Manchester, Manchester, UK.\', \'National Cancer Registration and Analysis Service, Public Health England, London, UK.\', \'Centre for Reviews and Dissemination, University of York Alcuin College, York, UK.\', \'Paediatric Oncology, Leeds Children\'s Hospital, Leeds, West Yorkshire, UK.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}